On June 19, 2017, Stryker Corporation announced a definitive agreement to acquire NOVADAQ Technologies Inc. for US$701 million. NOVADAQ'S innovative fluorescence imaging technology will expand Stryker’s product offerings into open and plastic reconstructive surgery.
Stryker Corporation is one of the world's leading medical technology companies. Stryker offers a diverse array of innovative products and services in Orthopaedics, Medical and Surgical, and Neurotechnology and Spine that help improve patient and hospital outcomes and is active in over 100 countries.
NOVADAQ is a leading developer of fluorescence imaging technology that provides surgeons with visualization of blood flow in vessels, and related tissue perfusion in cardiac, cardiovascular, gastrointestinal, plastic, microsurgical, and reconstructive procedures.
Osler, Hoskin & Harcourt LLP is representing Stryker with a team consisting of Jeremy Fraiberg and Alex Gorka (Corporate), Firoz Ahmed and Dov Begun (Tax), Shuli Rodal (Competition), Daniel Wong (Employment), and Jon Marin (Pensions and Benefits).